The Journal of Stem Cell Biology and Regenerative Sciences (JSCBRS) is an international, peer-reviewed, open-access journal dedicated to publishing high-quality scientific research in the rapidly evolving fields of stem cell biology, regenerative medicine, tissue engineering, cellular therapy, and translational biomedical sciences. Established with the aim of advancing innovation and interdisciplinary collaboration, the journal serves as a global platform for researchers, academicians, clinicians, and healthcare professionals to disseminate cutting-edge discoveries and evidence-based advancements in regenerative sciences.
The journal publishes original research articles, systematic reviews, meta-analyses, case reports, short communications, technical notes, clinical investigations, and emerging concepts related to stem cells and regenerative therapeutics. JSCBRS aims to bridge the gap between laboratory-based discoveries and clinical applications by promoting translational research that contributes to the advancement of personalized medicine, tissue regeneration, and biologically driven therapeutic strategies.
The full text of all published articles is freely accessible online, ensuring unrestricted dissemination of scientific knowledge to researchers, institutions, healthcare professionals, and students worldwide. The journal supports the principles of open-access publishing and encourages the free exchange of scientific information to accelerate innovation, collaboration, and clinical translation in regenerative medicine.
Aims and Scope
The Journal of Stem Cell Biology and Regenerative Sciences focuses on multidisciplinary research areas associated with stem cells, regenerative medicine, and advanced biomedical sciences. The journal welcomes contributions from basic science, translational research, and clinical applications across diverse medical and biological disciplines.
The scope of the journal includes, but is not limited to:
Stem Cell Biology: Research involving embryonic stem cells, adult stem cells, induced pluripotent stem cells (iPSCs), mesenchymal stem cells, hematopoietic stem cells, neural stem cells, and cancer stem cells.
Regenerative Medicine: Studies focused on tissue regeneration, organ repair, regenerative therapeutics, wound healing, and biologically engineered treatment approaches.
Tissue Engineering and Biomaterials: Research on scaffolds, bioactive materials, nanomaterials, hydrogels, bioprinting technologies, and tissue-engineered constructs for regenerative applications.
Cellular and Gene Therapy: Investigations related to cell-based therapies, gene editing technologies, CRISPR applications, exosome therapy, and molecular regenerative strategies.
Translational and Clinical Research: Clinical trials, translational medicine, precision therapeutics, and evidence-based regenerative interventions in medical and dental sciences.
Orthopedic and Musculoskeletal Regeneration: Research involving bone regeneration, cartilage engineering, tendon repair, spinal regeneration, and musculoskeletal tissue reconstruction.
Dental and Craniofacial Regeneration: Studies related to dental pulp stem cells, periodontal regeneration, craniofacial tissue engineering, oral regenerative therapies, and maxillofacial reconstruction.
Neuroregeneration and Neurosciences: Investigations focused on neural repair, spinal cord injury regeneration, neurodegenerative disorders, and stem-cell-based neurological therapies.
Cardiovascular and Organ Regeneration: Research involving cardiac tissue engineering, liver regeneration, pancreatic regeneration, renal tissue engineering, and organoid technologies.
Cancer and Regenerative Oncology: Studies exploring cancer stem cells, tumor microenvironment interactions, regenerative oncology, and targeted cellular therapies.
Immunology and Regenerative Biology: Research related to immune modulation, inflammatory pathways, regenerative immunotherapy, and host–cell interactions.
Artificial Intelligence and Emerging Technologies in Regenerative Sciences: Applications of artificial intelligence, machine learning, computational biology, digital pathology, and bioinformatics in regenerative medicine and stem cell research.
Biomedical Ethics and Regulatory Sciences: Articles discussing ethical considerations, regulatory frameworks, clinical governance, and policy development related to stem cell therapies and regenerative medicine.
The journal encourages interdisciplinary collaboration and promotes innovative scientific approaches that contribute to improving patient care, healthcare outcomes, and future regenerative therapies.
Ownership and Management
The ownership and management of the Journal of Stem Cell Biology and Regenerative Sciences are held by Font Fusions Publication Pvt. Ltd., an academic publishing organization committed to promoting high-quality scholarly communication and scientific advancement across multidisciplinary domains.
About the Publisher
Font Fusions Publication Pvt. Ltd. is dedicated to advancing academic excellence and scientific innovation through the publication of high-quality peer-reviewed journals. The publishing house aims to provide researchers, clinicians, and academicians with accessible and reliable platforms for disseminating scientific discoveries and evidence-based knowledge.
The publisher strongly supports the open-access publishing model, ensuring that scientific literature remains freely available to the global research community without financial or institutional barriers. By promoting unrestricted access to scholarly content, Font Fusions Publication facilitates academic collaboration, interdisciplinary integration, and rapid dissemination of scientific advancements.
The publishing team maintains rigorous editorial and ethical standards throughout the peer-review and publication process, ensuring transparency, integrity, and scientific credibility in all published work.
Publication Frequency
The Journal of Stem Cell Biology and Regenerative Sciences is published Quarterly and accepts submissions throughout the year. The journal follows a continuous publication model to ensure timely processing, peer review, and dissemination of accepted manuscripts.
Copyright and Licensing
All articles published in the Journal of Stem Cell Biology and Regenerative Sciences are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). This license permits unrestricted non-commercial use, distribution, reproduction, and adaptation of the published material in any medium, provided appropriate credit is given to the original authors and source.
Authors retain copyright ownership of their published work while granting publishing and distribution rights to the publisher. Authors are also permitted to archive the final published version of their manuscript in institutional repositories, personal websites, or subject-specific repositories in accordance with the journal’s self-archiving policy.
For commercial reuse, redistribution, or reproduction requests, prior written permission from the publisher is required.
Why Open-Access Publishing?
Open-access publishing plays a critical role in accelerating scientific progress and improving the global accessibility of research findings. Subscription-based access models often restrict the dissemination of scientific knowledge, particularly in developing regions and resource-limited academic settings.
The Journal of Stem Cell Biology and Regenerative Sciences supports unrestricted access to scientific literature, enabling researchers, clinicians, educators, and students worldwide to access, share, and build upon published research without barriers. By adopting an open-access framework, the journal promotes greater scientific visibility, increased citation potential, interdisciplinary collaboration, and faster translation of research into clinical practice.
Self-Archiving Policy for Authors
The journal encourages authors to archive the final published PDF version of their articles in institutional repositories, academic databases, and non-commercial subject repositories immediately after publication. Authors may also share article abstracts, citation information, and DOI links through academic networking platforms, institutional websites, and social media channels with appropriate attribution to the journal and publisher.
Preprint submissions are permitted provided that authors disclose relevant preprint details during manuscript submission. Following publication, authors should update the preprint record with the final publication citation and DOI information.
Editorial and Ethical Standards
The Journal of Stem Cell Biology and Regenerative Sciences follows internationally recognized ethical publishing standards and editorial best practices. All submitted manuscripts undergo rigorous peer review to ensure scientific quality, originality, methodological validity, and ethical compliance.
The journal adheres to principles related to publication ethics, conflict of interest disclosure, plagiarism screening, research integrity, informed consent, ethical approval, and transparency in scientific reporting. Manuscripts involving human participants, animal studies, stem cell experimentation, or clinical investigations must comply with relevant ethical and regulatory guidelines.
Editorial decisions are based solely on scientific merit, originality, and relevance to the journal’s scope, without influence from commercial interests or external sponsors.